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Abstract 
As the frequency and duration of space travel increase, the potential need for emergency medical care 
in space grows, and with it the need for patient monitoring devices supporting therapeutic treatment. 
Providing emergency care to an injured astronaut may necessitate immediate surgery. During such events, 
the timely administration of anesthetic agents will need to be performed by someone who is not a formally 
trained anesthesiologist. The availability of usable real-time displays of intravenous anesthetic 
concentrations and effects could significantly enhance intraoperative clinical decision-making both in space 
and on earth. The effectiveness of the real-time anesthesia display on the management of total intravenous 
anesthesia was determined by 31 anesthesiologists participating in a simulation study. In the presence of 
the anesthesia drug display, clinicians maintained physiologic indicators such as blood pressure and heart 
rate closer to baseline levels. Participants also reported an increase in perceived performance when using 
the drug display. The results indicate that surgeries on earth and in orbit would benefit from the 
implementation of this display. 
Introduction 
Monitoring devices that show intravenous (IV) 
drug concentrations and effects currently do not 
exist in space or in the modem operating room. 
However, the pharmacokinetic and 
pharmacodynamic models are available to estimate 
past, present and future effect site drug 
concentrations and associated physiological effects. 
An interdisciplinary research team (bioengineering, 
architecture, clinical anesthesia, and cognitive 
psychology) developed a graphic display that 
shows the predicted concentrations of intravenous 
drugs in real-time. 
During surgery, levels of sedation, analgesia 
and neuromuscular blockade are controlled by the 
timely administration of anesthetic drugs. Drugs 
are titrated while vital signs are monitored. The 
patient's response is observed until the desired 
effects are achieved. Compared with the 
administration of volatile anesthetics, this task is 
more demanding for increasingly popular IV 
anesthesia since drug plasma or effect site 
concentrations cannot be easily measured in real-
time. Accurate administration of anesthetic agents 
could also be further complicated in a zero gravity 
environment. 
Figure 1: The drug display showing drug doses, predicted effect site concentrations and predicted effects on 
sedation, analgesia and neuromuscular blockage. The three plots show trends (solid lines) and predictions 
(dashed lines) for the modeled effect site concentrations for the three classes of drugs. The current effect 
site concentrations are seen at time zero (just to the right of the middle of the display). Past history moves 
to the left of time zero (to -30 min) and the predicted future levels move to the right (to + 10 min). The bar 
graphs on the far right show the combined effects of all drugs administered on sedation, analgesia, and 
neuromuscular blockade. 
Multi-compartment pharmacokinetic models 
and their pharmacodynamic relationships have been 
developed that predict the arterial plasma and effect 
site concentrations for many intravenous 
anesthetics, analgesics, and neuromuscular 
blocking agents. These models permit the 
calculation of effect-site concentration for each 
agent, using iterative difference equations. \; 2 
When a bolus of drug is administered, the 
pharmacokinetic model can provide a prediction of 
the resulting effect site concentration. The model-
based predictions should provide a guide to drug 
administration resulting in better control of plasma 
drug concentrations. 
Our research group at the University of Utah 
developed and tested a prototype of a continuous 
display design containing predicted effect site 
concentrations and drug effects based on state-of-
the-art pharmacokinetic and pharmacodynamic 
models. The value of the prototype display to 
clinicians was assessed favorably as they delivered 
bolus doses of remifentanil and propofol using a 
software based patient simulator. 3 Results from 
this study led our development group to alter the 
prototype design in an effort to further improve 
performance. 
The new display (see Figure 1) can predict 
values for drugs administered in isolation and also 
when multiple drugs of the same class are used. 
Some drugs combined synergistic effects. Multiple 
drug effects and their interactions within a class 
and also between classes are also displayed. The 
information presented to the anesthesiologists is 
mapped to clinically relevant information rather 
than an arbitrary scale from zero to 100%. 
Figure 2. Sedative effect window. 
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Figure 2: Consciousness levels change with the predicted level of sedation. The OANS curve is drawn 
from the 5th to the 95 th percentile. Below the 95 th percentile, the patient's eyelids are open and the 
respiratory rate is 12 breaths/min. As the sedation level continues to increases above the 95 th percentile, the 
patient's eyelids close and the respiratory rate falls to 6 and then to 0 breaths/min. 
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"D rug Level" 
Figure 3: The drug level (effect-site concentration) for Analgesia. The fIrst curve corresponds to mild 
surgical stimuli and the second curve applies to laryngoscopy. When analgesia levels exceed the area under 
the curve the patient has sufficient analgesia for the type of stimulus. 
Examples of other changes made to the display are 
shown in Figures 2 and 3. Figure 2 shows the 
effect site concentration window for the sedative 
class of drugs as produced in the current iteration 
of the display. Within the effect site concentration 
window for sedatives the Observer's Assessment of 
Awake or Asleep Scale (OAAJS) sigmoidal 
function has been added to indicate the range of 
drug level to necessary to anesthetize 95% of the 
population. 
In Figure 3, the analgesic effect site 
concentration is shown. Within this display 
window sigmoidal curves indicate the level of 
analgesia relative to mildly painful surgical stimuli 
such as skin incision and severe surgical stimuli 
such as laryngoscopy. When the level of analgesia 
exceeds the area under the curve, the amount of 
analgesic is suffIcient to block pain for 95% of the 
population. Other changes include the mapping of 
the neuromuscular blockade effect site 
concentration to the train of four stimulus. The 
amount of neuromuscular blockade on board as 
shown in the display predicts accurately the amount 
of paralysis for 95% of the population. After these 
and other changes in the arrangement of 
information in the display, we tested the new 
iteration of the display design on a sample of 
anesthesiologists. 
In this study we test the hypothesis that 
pharmacodynamic models which predict levels of 
sedation, analgesia and neuromuscular blockade, 
help the clinician to choose the optimum 
combinations of drugs; thus maximizing the desired 
therapeutic effects while minimizing adverse side 
effects. The new display should be able to help the 
anesthesiologist maintain levels of sedative, 
analgesic and neuromuscular blocking agents at 
levels appropriate for the changing demands of the 
surgical procedure relative to a control condition 
performing without the display. Pain response, 
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wake up time and duration of anesthetic should all 
be reduced in the display condition. A further 
hypothesis predicts that NASA-TLX workload 
assessments 4 would also indicate an overall 
reduction in perceived workload associated with 
improved performance. Additionally subjects 
should continue to subjectively rate the display 
favorably. 
The experimental task was made challenging 
by changing the needs of the surgeon, and thus the 
demands of anesthesia, midway through the 
simulated surgical procedure. As levels of painful 
stimulus change, anesthesiologists using the drug 
display should be better able to manage the 
changing needs of the patient relative to the control 
group. Additionally anesthesiologists were asked 




Thirty-one anesthesiologists and anesthetists with a 
range of clinical experience (CRNA, CA-2 and 
CA-3, and faculty) participated in this study. All 
participants were paid $50.00 for their participation 
in the study. All participants were affiliated with 
the University of Utah School of Medicine. 
Procedure 
Upon arriving at the Center for Patient 
Simulation, subjects completed a questionnaire to 
elicit their experience level, length of time working 
prior to the study, caffeine consumption, sleep 
history, color-vision, and whether they required 
vision correction. Subjects were instructed to 
provide anesthesia to a simulated patient during 
surgery using the total intravenous anesthesia 
method (TIVA). A standardized training (see 
below) followed where all participants were trained 
in the use of the drug display, instructed in the use 
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Figure 4: Diagram of the surgical procedure as a function of painful stimuli and time. Participants were 
required to administer appropriate analgesic and sedative for the changing dynamics of the surgical 
procedure. 
of the METI simulator, and the equipment used for 
the delivery of the drugs. 
Prior to beginning the simulation, participants 
reviewed the anesthesia record and patient 
information sheet providing them with medical 
information about the patient, including allergies 
and experienced past problems, and the planned 
procedure. Subjects then began to induce 
anesthesia, intubate the patient's trachea, and 
provide care for the simulated patient throughout a 
shoulder endoscopy procedure. Seventeen minutes 
into the endoscopy the surgeon announced that the 
originally planned scope procedure was not 
sufficient to repair the damaged shoulder, and that 
a more invasive Bankart procedure would need to 
be performed. The change in surgical procedure 
significantly altered the requirements for the 
delivery of anesthetics and the projected time 
requirements for the surgery (See Figure 4). After 
providing care for the duration of the surgical 
procedure the anesthesiologist extubated the patient 
and waited until the patient regained consciousness. 
After completing the simulation, the subjects 
answered a NASA-TLX questionnaire and a 
questionnaire about the drug display and the 
realism of the simulation. The experimental 
session lasted approximately ninety minutes, and 
the subjects were debriefed and compensated $50 
for their participation. 
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Aparati 
The MET! anesthesia simulator (MET!, 
Sarasota, FL.) at the University of Utah Center for 
Patient Simulation was used to conduct the 
simulation. An AS/3 anesthesia monitor (Datex, 
Helsinki, Finland) displayed the traditional 
electrocardiogram (ECG), arterial blood pressure 
(BP), pulse oximeter (Sp02), and capnogram 
(C02) waveforms. Digital values for heart rate 
(HR), blood pressure (BP), oxygen saturation 
(Sp02), end-tidal carbon dioxide (FetC02), and 
fraction of inspired oxygen (Fi02) were displayed 
in addition. The pulse oximeter tone was also 
provided. Alarms were set to default mode. The 
drug display (Figure 1) was shown on a 17-inch 
monitor placed beside the AS/3 monitor. 
Training 
A computerized tutorial was presented to each 
subject in order to provide standardized training in 
use of the drug display for all subjects. Subjects 
viewed static screen shots of the drug display 
monitor depicting the effect site concentrations and 
current effects of propofol, remifentanil, fentanil, 
and rocuronium on sedation, analgesia and 
neuromuscular blockade. The display was 
explained in detail including: axes, labels, drug 
classifications, effect site concentrations according 
to clinically relevant variables, the effect bars, 
effect site concentration and its relation to drug 
effect, predicted, past, and present concentrations. 
The participants were told the display shows 
estimated effect site concentrations and drug effects 
generated from pharmacodynamic models. 
A minimum amount of training was required 
for the METI high fidelity simulator because most 
subjects were familiar with the simulator from 
previous exposure as part of their anesthesia 
training. All subjects were instructed in the use of 
the drug delivery systems. To demonstrate 
proficiency in use of the drug delivery system, each 
subject administered a fixed infusion rate and a 
specified bolus dose as practice. Training for the 
simulator was completed when the subject reported 
feeling comfortable with administration of the 
anesthetic agents in the simulated patient. On 
average, the training took 20 minutes. Half of the 
subjects were then assigned randomly to the drug 
display condition and the remaining half were 
assigned to the control condition. 
Surgical Scenario 
Prior to starting the simulation, the subjects 
were given the patient's preanesthetic evaluation 
form including: the patient's medical and surgical 
history, labs, baseline vital signs, planed surgical 
procedure, and the expected duration of the 
surgery. The patient was presented as having 
arrived in the operating room without prior 
sedation or pre-oxygenation; however, ECG 
electrodes, an IV, an arterial line, and a non-
invasive blood pressure cuff were already in place. 
The anesthesiologist was told the patient was 
scheduled to receive a routine shoulder endoscopy 
to repair minor damage, a procedure usually lasting 
about 25 minutes. The subject was reminded that 
he or she may administer boluses or continuous 
infusions of propofol and remifentanil, as well as 
bolus doses of fentanyl and rocuronium. Antagonist 
drugs and other cardiovascular agents were not 
available for use. The subject was given a new 
anesthetic record and was reminded to keep the 
record during the course of the simulation 
Data Collection 
During the simulated surgery, predicted effect 
site concentrations of all administered drugs and 
model predicted levels of sedation, analgesia, and 
NMB were recorded. Patient vital signs were also 
recorded during the surgery. Minimum, maximum, 
mean, and percent deviations from baseline were 
calculated for heart rate, systolic, diastolic and 
mean blood pressure. The values of the vital signs 
were recorded at four-second intervals and the 
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effect site concentrations of all administered drugs 
were recorded at two-second intervals. The time 
duration from completion of skin closure to 
awakening (spontaneous respiration and eyes 
opening) and extubation were recorded. 
Data Analysis 
Pain Response 
The goal during the surgery is to keep the vital 
signs as stable as possible, reducing patient risk. 
Thus the dependent measures for the difficult to 
manage Bankhart procedure were analyzed. 
Performance in analgesia management was 
measured by comparing the pharmacodynamic 
predicted level of analgesia with the level of 
surgical stimulation (Figure 4). Since the simulator 
was calibrated such that cardiovascular responses 
matched the pharmacodynamic predictions, 
subjects with and without the drug display had the 
same cardiovascular information available. Heart 
rate (HR) and mean arterial blood pressure (MAB) 
were used to measure periods when the patient 
responded adversely to pain. 
Wake Up Time 
To determine the time it took to wake the 
patient up, we measured the time between skin 
closure and the time when the patients eyes opened 
and had a respiratory rate of 6 breath per minute. 
Total Time 
The time for patient emergence was measured 
by determining the time between induction of 
anesthesia (the time of eye closure and respiratory 
rate of zero) and the patients eye-opening and 
return of the respiratory rate to 6 breath per minute. 
Questionnaires 
The mean and standard deviations of the 
scores were computed for the participants' answers 
to the NASA-TLX workload survey and the first 
question of the evaluation questionnaire regarding 
display usefulness. Ratings pertaining to the 
realism of the simulated surgery were also solicited. 
Pain Response 
Overall analyses of pain response during the 
Bankhart procedure (unexpected and requiring 
changes in the anesthesia plan) indicate 
performance differences observed were due to the 
presence of the drug display. When 
anesthesiologists were using the drug display, their 
level of performance was higher indicated by 
T bl I P . R a e am esponse 
Drug display Control 
HR 65.4 (12.4) 57.4 (14.1) 
MAB 90.1 (19.8) 79.6 (17.8) 
Pain score .67 (Ll) 1.2 (1.4) 
Table 1. Means (standard deviations) for heart 
rate, mean arterial blood pressure, pain scores 
during the Bankhart procedure. 
higher mean arterial blood pressure, higher heart 
rate, and lower pain levels than the performance of 
the control group (See Table 1). 
As painful stimuli occur, the associated pain 
score (0-10) is compared with the predicted 
analgesic level (0-10). If the level of analgesia is 
below the pain score, the cardiovascular variables 
increase above baseline simulating a cardiovascular 
response. If the level of analgesia is higher than the 
pain score, the cardiovascular variables are lower 
than baseline. 
Analyzing the patient's heart rate during the 
Bankhart procedure revealed a main effect of 
display condition (F(I,25)=4.87; p=.037), with 
average heart rate closer to baseline when subjects 
were using the drug display. 
Analyzing the mean arterial blood pressure 
during the Bankhart procedure showed that subjects 
in the drug display condition were able to keep the 
blood pressure of the patient closer to baseline 
levels than anesthesiologists who were in the 
control group (F(I,25)=4.379;p=.047). 
Analyzing the level of control for pain showed 
a similar picture as the analyses of heart rate and 
mean arterial blood pressure. Again, there is a 
reliable difference between the display condition 
and the control condition (F(I,25)=5.507;p=.027), 
with lower levels of pain in the group where 
anesthesiologists were using the drug display. 
Wake Up Time 
The same design as described above was used 
to analyze the time for emergence from anesthesia 
(see Table 2). Analyzing the time until eye 
opening showed a significant main effect of 
condition (F(I ,29)= 4.26; p=.05). Patients who 
were treated in the drug display condition woke up 
more than two minutes earlier than patients treated 
without using the drug display. 
Analyzing the time for respiratory rate 
reaching the criterion of 50% of the baseline level 
shows a main effect of condition (F(1,29)=11.39; 
p=.003) with patients reaching this respiratory rate 
more than three minutes faster when they were 
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T bl 2 W k U T a e a e JP illle 
Drug Control 
display 
Opening eyes 736 (160) 862 (176) 
Respiration 50% 577 (148) 774 (176) 
Table 2. Tillle (standard deVIatIOns) m seconds 
during the wake up time interval and recovery of 
respiratory rate to 50% of baseline. 
treated by an anesthesiologist in the drug display 
condition. These results indicate there was a strong 
effect of the display condition on performance. 
Shorter wake up latencies were observed and 
respiratory rate returned to normal more quickly 
when the patient was treated by an 
anesthesiologists using the drug display. 
Total Time 
Another way to analyze the performance in 
terms of the quality of delivering anesthesia is to 
look at the overall duration of the procedure. Since 
the surgical portion of the procedure was consistent 
between subjects, the differences in total time can 
be attributed to display condition. The data were 
analyzed by using the total time for the surgical 
procedure from the beginning of the preoperative 
phase to the point of extubation of the patient. The 
ANOV A revealed a main effect of condition 
(F(1 ,30)=4.73 ; p=.039), with anesthesia being 
delivered more efficiently when patients were 
treated by anesthesiologists using the drug display 
(see Table 3). The results again indicate there was 
a strong effect of the display condition on 
performance. Shorter procedure durations were 
observed when the anesthesiologists used the drug 
display. 
Questionnaire data 
The analyses of the NASA TLX revealed a 
reliable difference between conditions in terms of 
subjective performance (F(I ,30)=4.44; p=.045). 
Subjects who were using the drug display rated 
Table 3 Total Time 
Drug Control 
display 
Total time for 2826 (542) 3215 (640) 
procedure 
{ 4 7 minutes} {54 minutes} 
Table 3. Total procedure tIme m seconds (standard 
deviation) for the drug display and the control 
condition. Below is the total time in minutes. 
their subjective performance higher (5.9 (1.6)) than 
subjects in the control group (4.5 (2.0)). 
Analyzing subjects' impression about the 
fidelity of the simulation showed no difference 
between the two display conditions. All subjects 
thought the display should be added to their current 
monitoring capabilities. 
Discussion 
The results suggest that visualizing real-time 
drug pharmacokinetics and pharmacodynamics as 
drugs are administered results in better control of 
drug concentrations, more stable vital signs and an 
increase in perceived performance. 
Anesthesiologists more accurately controlled 
effect-site concentration of sedatives, analgesics 
and neuromuscular blockade when using the drug 
display, and this resulted in a more stable heart rate 
and fewer instances of hemodynamic response to 
pam. 
This study supports the idea that observing the 
effect site concentrations of intravenous drugs 
helps clinicians to maintain drug levels within the 
"therapeutic window" . As a result, there will be a 
decrease in intraoperative awareness, undesirable 
hemodynamic responses to pain and an 
improvement in the control of neuromuscular 
blockade with the use of such a display. 
Results from the NASA- TLX indicate an 
increase in perceived performance associated with 
anesthesia administration while using the drug 
display. Participants also rated the display as a 
useful addition to the operating room. 
In sum the results of this study indicate that 
anesthesiologists performance during surgery can 
be facilitated with the additional information 
provided in the drug display. This facilitation of 
performance will hopefully result in fewer critical 
events during surgery as well as post surgical injury 
associated with improper anesthetic administration. 
With the certain probability of the necessity for 
critical care in outer space, the means for 
displaying accurate and important information 
about a patient's status to an attending physician or 
astronaut is paramount. A display such as the 
design presented in this report may help to assist 
clinical decision making and critical care of 
patients in the modem day operating room and 
space travelers in orbit and beyond. 
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